iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
Portfolio
World-leading surgeons to join iSTAR Medical’s STAR-V study WAVRE, Belgium — 15 July 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to start a pivotal trial with MINIjectTM. The STAR-V study will investigate MINIjectTM […]
Do you want to stay updated about the press releases?